— 
| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 4mg | 28 pill | AUD204.51 | AUD6,736.89 AUD5,726.36 Best Price Popular | |
| 4mg | 14 pill | AUD207.44 | AUD3,416.56 AUD2,904.08 | |
| 4mg | 7 pill | AUD211.82 | AUD1,744.36 AUD1,482.71 |
Disclaimer: This information is for Australian patients and is not a substitute for advice from a doctor or pharmacist. Always consult a healthcare professional for medical advice tailored to you.
Olumiant is an oral medicine that contains the active ingredient baricitinib. It works by modulating parts of the immune system to reduce inflammation.
In Australia, Olumiant may require a prescription depending on local rules. It is used for certain inflammatory conditions when other treatments have not provided enough benefit or are not suitable.
Olumiant is taken as tablets, with dosing determined by your clinician. The duration of treatment can vary based on how you respond and any side effects you may experience.
Use Olumiant exactly as your doctor has told you. If you have questions about why it has been prescribed for you, ask your doctor or pharmacist for clarification.
Olumiant is intended for adults with certain inflammatory conditions where there is an immune system component. It may be used when other treatments have not achieved the desired effect or are not suitable for you. The exact approved indications in Australia are described in the official patient information and product labeling.
In some cases, Olumiant may be prescribed for other approved indications as decided by a clinician. Always follow the specific instructions provided by your healthcare professional. Do not use Olumiant for a condition it has not been prescribed for you.
The decision to start Olumiant depends on your medical history, other medicines you take, and your risk of infections or other side effects. Your clinician will explain the expected benefits and potential risks for your situation.
If you have questions about whether Olumiant is right for you, or about the approved indications in Australia, please consult your doctor or pharmacist. They can provide the most current information for your location.
Baricitinib blocks certain enzymes in the JAK signaling pathway, notably JAK1 and JAK2. These enzymes help messages pass inside immune cells to promote inflammation.
By reducing these signals, Olumiant can lessen inflammation and related symptoms in some conditions. The effect on the immune system can also mean a higher chance of infections while taking the medicine.
This mechanism targets specific inflammatory pathways rather than acting as a broad immune suppressant. Your clinician will discuss how this relates to your condition and what monitoring may be needed.
Response to Olumiant varies between individuals. Some people notice improvement after weeks, while others may take longer or may not respond. Discuss what you should expect with your doctor or pharmacist.
Take Olumiant exactly as prescribed by your doctor. The tablets should be swallowed whole with a glass of water. Do not crush, chew, or break the tablets unless advised by your clinician.
The usual dosing schedule is determined by your clinician and may be once daily. Try to take Olumiant at about the same time each day to help you remember. Do not change the dosing or stop taking it without speaking to your clinician.
If you miss a dose, do not double up. If you realise you have missed a dose, take the next dose as planned unless your clinician tells you otherwise. If you are unsure what to do, contact your pharmacist or doctor for guidance.
Store Olumiant at room temperature, away from moisture and heat. Keep it in its original packaging and out of reach of children. Do not use Olumiant after the expiry date printed on the packaging.
Do not take Olumiant if you have a current serious infection. Because it affects the immune system, it can increase the risk of infection or worsen existing infections. If you develop an infection, inform your clinician promptly.
Tell your clinician if you have a history of blood clots, liver or kidney problems, or certain blood disorders. These conditions may require extra monitoring or adjustments to your treatment.
Pregnant or breastfeeding individuals should discuss risks and alternatives with their clinician. The safety of Olumiant during pregnancy or while breastfeeding has not been established for all indications.
Olumiant may interact with vaccines and other medicines. Inform your doctor about all medicines you take, including over‑the‑counter drugs, vitamins, and herbal products. They can advise on suitability and monitoring requirements.
There is a potential increased risk of infections with Olumiant. Contact your clinician if you develop fever, cough, sore throat, or other signs of infection.
There is also a potential risk of blood clots with JAK inhibitors. Seek urgent medical help if you notice chest pain, swelling in the leg, or sudden shortness of breath.
Your health care provider may request laboratory tests to monitor blood counts, liver function, and lipid levels while you are on Olumiant. Attend all scheduled tests and discuss results with your clinician.
Discuss any health changes or new medications with your clinician, including vaccines. Live vaccines may be affected by Olumiant, so a clinician can provide guidance on timing and safety.
Report any unusual or persistent symptoms to your doctor, such as severe abdominal pain, yellowing of the skin, dark urine, or unusual fatigue. Regular monitoring helps manage potential risks.
Like all medicines, Olumiant can cause side effects in some people. Most side effects are mild to moderate and may improve with time or adjustments in treatment.
Common side effects may involve the digestive system or respiratory tract. Some people may experience headaches or fatigue during treatment.
You may notice changes in blood test results or lipid levels. Your clinician may review these results to determine whether any action is needed.
Very rare but potentially serious reactions can occur. Seek medical attention promptly if you develop symptoms such as severe allergic reactions, signs of infection that do not improve, or unexplained bruising or bleeding.
Inform your doctor about all medicines you take, including over-the-counter drugs, vitamins, and herbal supplements. Some medicines can interact with Olumiant and affect safety or how well it works.
Medicines that suppress the immune system or treat cancer may increase the risk of infections when used with Olumiant. Your clinician may adjust treatment or monitoring if these medicines are required together.
Live vaccines may not be recommended while using Olumiant. Discuss vaccination plans with your doctor to determine what is safe for you during treatment.
If you are considering starting any new medicine or supplement, check with your doctor or pharmacist first. They can advise on potential interactions and what to monitor for.
There may be risks to a developing baby if you take Olumiant during pregnancy. If you are planning pregnancy or discover you are pregnant, talk with your clinician promptly to understand options and risks.
Contraception during treatment with Olumiant should be discussed with your clinician. If you are planning to become pregnant, or if pregnancy occurs, seek medical advice as soon as possible.
Breastfeeding while taking Olumiant is generally not advised. Discuss with your healthcare provider whether alternative medicines or temporary cessation of breastfeeding is appropriate for you.
If you are pregnant, planning pregnancy, or breastfeeding, do not change your treatment plan without discussing it with your clinician. They can help you weigh benefits and risks for your situation.
The following questions address common concerns. If your question is not answered here, or you need personalised guidance, contact your doctor or pharmacist.
The time to notice improvement varies between individuals and conditions. Some people may see changes within weeks, while others may take longer. Your clinician will review your response at follow‑up appointments.
If you miss a dose, do not double up. Take the next dose as planned unless your clinician advises otherwise. If you are unsure what to do, contact a healthcare professional for advice.
Tell your clinician about all medicines and supplements you take. Some combinations may require closer monitoring or adjustment of treatment. Do not start new medicines without professional guidance.
Contact your doctor if you develop signs of infection, chest pain, shortness of breath, severe abdominal pain, yellowing of the skin, or any other concerning symptoms. Seek urgent medical help if you have sudden severe symptoms suggestive of a serious reaction.
Some vaccines may be unsuitable or require timing adjustments while on Olumiant. Discuss your vaccination plan with your clinician to determine what is safe during treatment.
Avoid or limit alcohol while taking Olumiant if you have liver concerns or if your clinician has advised so. Discuss any questions about alcohol use with your doctor or pharmacist.
Store the tablets in their original packaging at room temperature, away from moisture and heat. Keep out of reach of children. Do not use after the expiry date.
Your clinician may order blood tests to monitor blood counts, liver function, and lipids. Attend all scheduled tests and discuss results with your doctor.
Do not stop taking Olumiant without medical advice. Stopping treatment abruptly can lead to a return of symptoms or other risks. Your clinician will guide a safe plan if you stop.
There may be risks to a baby if used during pregnancy or breastfeeding. Discuss these risks with your clinician. Do not rely on this information alone to make decisions about pregnancy or feeding.
14–21 days. Free from AUD292.16 .
5–9 days. AUD43.82
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.